Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis

BACKGROUND: The preferred regimen for HIV post-exposure prophylaxis (PEP) is based mainly on safety and tolerability because it is given to immunocompetent people without HIV infection for a limited time (28 days). The frequency of adverse events (AEs) may be > 60%. Although AEs are generally not...

Descripción completa

Detalles Bibliográficos
Autores principales: Valin, Nadia, Fonquernie, Laurent, Daguenel, Anne, Campa, Pauline, Anthony, Theresita, Guiguet, Marguerite, Girard, Pierre Marie, Meyohas, Marie Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127047/
https://www.ncbi.nlm.nih.gov/pubmed/27894270
http://dx.doi.org/10.1186/s12879-016-2056-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127047/
https://www.ncbi.nlm.nih.gov/pubmed/27894270
http://dx.doi.org/10.1186/s12879-016-2056-3

Ejemplares similares